We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Professional CGM System Improves Glucose Control

By HospiMedica International staff writers
Posted on 25 Jun 2014
A professional continuous glucose monitoring (CGM) system allows doctors and patients to review glucose data retrospectively, assisting therapeutic treatment management.

The Dexcom G4 PLATINUM Professional CGM consists of a practice-owned professional CGM system and sensors. More...
Patients are first placed on the device for a period of seven days, with two calibration measurements using a blood glucose meter performed daily. Dynamic and comprehensive data is collected and shared with the patient, which aids in their understanding of the impact between behavior and glucose activity. Clinicians can use these insights to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress, and medications have on their glucose levels.

Following setup, the system provides continuous readings on the rate and direction of glucose change up to every five minutes, supporting therapy adjustments and treatment recommendations. The system can also be customized for personalized glucose targets and alerts, and has an alarm feature to alert the user if glucose levels rise or fall to dangerous levels. The system has an extended 6-meter range1, and a sleek receiver available in three vibrant colors. The Dexcom G4 PLATINUM Professional CGM is a product of Dexcom (San Diego, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Dexcom’s mission is to provide doctors, patients and caregivers new medical technology to improve their understanding and management of diabetes,” said Terrance H. Gregg, CEO of Dexcom. “The G4 PLATINUM Professional is Dexcom’s latest answer for healthcare professionals and patients seeking novel and insightful tools to optimize therapeutic decisions.”

The traditional standard-of-care for glucose monitoring is a finger stick meter. CGM thus represents the most significant breakthrough in diabetes management in the past 40 years, augmenting the use of glucose meters for the management of diabetes by providing real-time glucose changes with the push of a button, alerting users when glucose is too low or too high. Finger stick meters are still required to calibrate CGMs and for making therapy and meal decisions.

Related Links:

Dexcom



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Shoulder System
Identity Shoulder System
New
Drying Cabinet
Scope Drying Cabinet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.